Calliditas Therapeutics’ 2022 Annual Report Published
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2022 now is available at the company’s website: www.calliditas.com For further information, please contact: Åsa Hillsten, Head of Investor Relations, Calliditas Therapeutics AB Phone: +46 764 03 35 43 E-mail: asa.hillsten@calliditas.com This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 21:00 CET on April 26, 2023. About Calliditas